Applied DNA Sciences, Inc. | WebDisclosure

Basculer en Français

8295	Companies
114863	Keywords
55304	Articles
62446	Press releases

Headlines Articles Press releases Applied DNA Sciences, Inc.

Home
Companies
Applied DNA Sciences, Inc.

BRIEF

published on 08/08/2024 at 22:15, 3 months 12 days ago

Applied DNA publie ses résultats financiers du troisième trimestre de l'exercice 2024

Résultats Financiers Baisse Des Revenus ADN Appliqué 3e Trimestre 2024 Mises À Jour Opérationnelles
PRESS RELEASE

published on 08/08/2024 at 22:10, 3 months 12 days ago

Applied DNA Announces Third Quarter Fiscal Year 2024 Financial Results
Applied DNA Sciences, Inc. announces third quarter financial results for June 30, 2024, including operational highlights and future plans. Conference call/webcast today at 4:30 PM ET. View Form 10-Q at https://investors.adnas.com/sec-filings/

Financial Results Conference Call Applied DNA Sciences PCR-based DNA Technologies Consolidated Financial Results
BRIEF

published on 07/29/2024 at 18:02, 3 months 22 days ago

Applied DNA pour mettre en avant la plateforme Linea IVT lors du Sommet thérapeutique basé sur l'ARNm

Biotechnologie Sciences Appliquées De L'ADN Plateforme Linea IVT Thérapeutique À Base D'ARNm Contamination Par ARNdb
BRIEF

published on 07/29/2024 at 18:02, 3 months 22 days ago

Applied DNA to Highlight Linea IVT Platform at mRNA-based Therapeutics Summit

Biotechnology Applied DNA Sciences MRNA Therapeutics Linea IVT Platform DsRNA Contamination
PRESS RELEASE

published on 07/29/2024 at 17:57, 3 months 22 days ago

CORRECTING AND REPLACING: Applied DNA to Showcase Linea IVT as a High-yield, dsRNA-Mitigated Platform for the GMP Manufacture of RNA at the 4th Annual mRNA-based Therapeutics Summit
Applied DNA Sciences, Inc. presents Linea IVT platform for enhanced mRNA production at 4th Annual mRNA-based Therapeutics Summit. Solution reduces dsRNA contamination, streamlines workflows, and boosts efficiency

Applied DNA Sciences MRNA Therapeutics Linea IVT Platform MRNA Production DsRNA Contamination
BRIEF

published on 07/18/2024 at 16:05, 4 months 2 days ago

U.S. Defense Logistics Agency Exercises 1-Year Option Period in Applied DNA Counterfeit Mitigation Contract

Applied DNA Sciences PCR-based DNA Technologies Defense Logistics Agency Counterfeit Mitigation Microcircuits
BRIEF

published on 07/18/2024 at 16:05, 4 months 2 days ago

L'Agence américaine de logistique de défense exerce une période d'option d'un an dans le cadre d'un contrat d'atténuation de la contrefaçon d'ADN appliqué

Sciences Appliquées De L'ADN Technologies D'ADN Basées Sur La PCR Microcircuits Agence De Logistique De Défense Atténuation De La Contrefaçon
PRESS RELEASE

published on 07/18/2024 at 16:00, 4 months 2 days ago

U.S. Defense Logistics Agency Exercises 1-Year Option Period in Applied DNA Counterfeit Mitigation Contract
Applied DNA Sciences announces $1.04 million contract with U.S. Defense Logistics Agency for counterfeit mitigation and product verification programs specific to FSC 5962 microcircuits. Continues support since 2014

Applied DNA Sciences DNA Technologies Defense Capabilities Counterfeit Mitigation DLA
BRIEF

published on 06/20/2024 at 15:20, 5 months ago

Applied DNA and Alphazyme Achieve Major Cost Reduction in Linea RNAP Manufacturing

Cost Reduction MRNA Production Alphazyme Linea RNAP Applied DNA
BRIEF

published on 06/20/2024 at 15:20, 5 months ago

Applied DNA et Alphazyme permettent de réduire considérablement les coûts de fabrication de Linea RNAP

Réduction Des Coûts Production D'ARNm Alphazyme Ligne RNAP ADN Appliqué

Accesswire

Published on 11/21/2024 at 12:00, 49 minutes ago

Alset AI Announces Full Repayment of $3.7 Million Secured Loan with Interest from Portfolio Company, Significantly Strengthening Balance Sheet
Published on 11/21/2024 at 12:00, 49 minutes ago

Battery X Metals Commences Strategic Initiatives to Strengthen Balance Sheet
Published on 11/21/2024 at 11:30, 1 hour 19 minutes ago

FireFox Trenching Returns More High-Grade Gold at the Mustajärvi Gold Project in Lapland, Finland
Published on 11/21/2024 at 10:03, 2 hours 46 minutes ago

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 2 hours 49 minutes ago

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 12:35, 13 minutes ago

audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 34 minutes ago

Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 12:06, 42 minutes ago

IVU AG publishes Quarterly Report Q3-2024
Published on 11/21/2024 at 12:00, 48 minutes ago

Holding(s) in Company
Published on 11/21/2024 at 11:30, 1 hour 19 minutes ago

APONTIS PHARMA AG: Condition of Minimum Acceptance in Zentiva’s Voluntary Public Purchase Offer Waived

Les Echos

Published on 11/21/2024 at 06:58, 5 hours 51 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 5 hours 51 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 5 hours 51 minutes ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 16 hours 41 minutes ago

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 17 hours 29 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

View all LES ECHOS COMFI WIRE